BREAKING
CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 1 hour ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 13 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 13 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 17 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 18 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 20 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 22 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 1 day ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 1 day ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 1 day ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 1 hour ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 13 hours ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 13 hours ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 17 hours ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 18 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 20 hours ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 22 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 1 day ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 1 day ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 1 day ago
ADVERTISEMENT
AlphaGraphs

Dentsply Sirona (XRAY) slips to a loss in Q1 but beats estimates

Dentsply Sirona Inc. (NASDAQ: XRAY) reported its preliminary financial results for the quarter ended March 31, 2020, on Friday before the bell. The results exceeded analysts’ expectations. Dentsply Sirona slipped to a loss in the first quarter of 2020 from a profit last year, due to an Equipment & Instruments non-cash goodwill impairment and an […]

$XRAY May 8, 2020 1 min read

Dentsply Sirona Inc. (NASDAQ: XRAY) reported its preliminary financial results for the quarter ended March 31, 2020, on Friday before the bell. The results exceeded analysts’ expectations.

Dentsply Sirona slipped to a loss in the first quarter of 2020 from a profit last year, due to an Equipment & Instruments non-cash goodwill impairment and an intangible impairment. The Equipment & Instruments unit showed weakness in sales due to the ongoing COVID-19 impact on customer demand.

Dentsply Sirona (XRAY) Q1 2020 earnings review

The dentists and customers reduced dental visits and procedures in response to the coronavirus pandemic. As a result of the uncertainty around the duration of the COVID-19 pandemic and its impact on the business, the company previously withdrew its 2020 guidance.

During the first quarter, the company bought back shares for a total cost of $140 million. In addition, the company paid $22.1 million in dividends resulting in a total of $162.1 million returned to shareholders during the first quarter of 2020.

ADVERTISEMENT
Take a look at the rest of our Healthcare articles here
ADVERTISEMENT